ClinicalTrials.Veeva

Menu

Supplementing Brief Psychotherapy With a Mobile App

Rutgers The State University of New Jersey logo

Rutgers The State University of New Jersey

Status

Completed

Conditions

Emotion Regulation
Suicide and Self-harm

Treatments

Behavioral: Unified Protocol

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05867316
R34MH113757 (U.S. NIH Grant/Contract)
Pro2022001944

Details and patient eligibility

About

Suicide is among the leading causes of death worldwide, and the risk of suicide is highest in the period immediately following discharge from inpatient psychiatric care.1Importantly, despite the enormously elevated risk during this period, nearly 50% of patients do not attend scheduled therapy after discharge. Even among those who do attend therapy, however, the skills learned in treatment may be difficult to use during the highly distressing time leading up to and during a suicide crisis. Most traditional treatments are not designed to be effective during a suicide crisis. In order to reduce the risk of suicidal thoughts and behaviors in general and specifically during the post-discharge period, interventions are needed that: (1) are easily adhered to and (2) are accessible and effective during a suicide crisis. As such, the purpose of this research study is to test an innovative, new intervention in order to develop an effective and accessible intervention for those at high risk for suicide

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Adult status (18+ years)
  • Admission to eligible units in our partner hospital with a reason for admission having to do with suicide risk
  • The ability to speak and write English fluently,
  • Ownership of and consistent access to an internet-capable smartphone (e.g., an iPhone or Android phone)

Exclusion Criteria

  • The presence of any factor that impairs an individual's ability to provide informed consent and comprehend and effectively participate in the study including: an inability to speak or write English fluently, the presence of gross cognitive impairment due to florid psychosis, intellectual disability, dementia, acute intoxication, or the presence of extremely agitated or violent behavior.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

Unified Protocol
Experimental group
Description:
Unified Protocol-based treatment, with three sessions
Treatment:
Behavioral: Unified Protocol

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Kate Bentley, PhD; Kleiman Lab Research Staff

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems